However, if future studies determine that the role of miR-26 delivery is selective for the treatment of Myc disorders, then the efficient delivery of this miRNA remains an important objective to achieve, as the therapeutic delivery of this miRNA will be effective for a large number of human cancer subtypes (Paquet et al., 2016). The gene discussed is MYC; the disease is cancer.